Probenecid and Colchicine NDC 16571-832

NDC codes

FDA NDC Directory

Product NDC (as listed)16571-832Labeler and product segments. Claims need a package NDC.

Product NDC at billing width16571-0832Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
16571-832-01	16571083201	100 TABLET in 1 CONTAINER (16571-832-01)Marketed from Oct 24, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Probenecid and Colchicine
Generic name (nonproprietary): probenecid and colchicine
Active ingredients: Probenecid — 500 mg/1Colchicine — .5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Rising Pharma Holdings, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217030
Marketing start: Oct 24, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Alkaloids (Chemical structure)
Identifiers: Product ID 16571-832_64aeee43-1864-41f8-8c65-bdcfb7d12142SPL ID 64aeee43-1864-41f8-8c65-bdcfb7d12142SPL set ID 3d2a3d4f-38a3-4669-ad78-ab1d7aef4ec3RxCUI 198153UNII PO572Z7917, SML2Y3J35T
Pharmacologic class: Alkaloid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N416571083201 followed by a unit qualifier and the quantity

Package 16571-0832-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 27, 2026.

Indications (excerpt from the label)

INDICATIONS & USAGE For the treatment of chronic gouty arthritis when complicated by frequent, recurrent acute attacks of gout.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 217030

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217030
Product	Strength	Form · route	Labeler	Product NDC
Probenecid and Colchicine	Probenecid 500 mg/1; Colchicine .5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4644